SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-17-010513
Filing Date
2017-03-03
Accepted
2017-03-03 16:06:01
Documents
7
Effectiveness Date
2017-03-03

Document Format Files

Seq Description Document Type Size
1 EDGE THERAPEUTICS, INC S-8 3-3-2017 (401(K) PROFIT SHARING PLAN) forms8.htm S-8 76447
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 11082
3 EXHIBIT 5.2 ex5_2.htm EX-5.2 16299
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 2439
5 image00001.jpg GRAPHIC 2362
6 image00004.jpg GRAPHIC 3899
7 image00006.jpg GRAPHIC 2995
  Complete submission text file 0001140361-17-010513.txt   120406
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216431 | Film No.: 17663576
SIC: 2834 Pharmaceutical Preparations